Australia's Lumos Diagnostics hits two-month high on upbeat Q3 results
** Shares of Lumos Diagnostics LDX.AX rise 11.5% to A$0.029, their highest level since February 28 ** Stock set for its strongest session since April 17, if current trends hold ** Medical equipment supplier posts 21% increase in Q3 revenue compared to its previous quarter ** About 6.1 mln shares change hands, 4.2x the 30-day average of 1.4 mln shares ** Stock down 17.1% YTD, including current session's moves (Reporting by Manasi Dasa in Bengaluru) ((Manasi.DasaSundeep@thomsonreuters.com;))
Recent news on Lumos Diagnostics Holdings
See all newsBrief: Lumos Diagnostics Posts FY26 Revenue Of $13.2 Million
Australia's Lumos Diagnostics soars on bagging purchase order for diagnostic test
Brief: Lumos Diagnostics Receives $767,800 Febridx Order From Phase Scientific
Brief: Lumos Diagnostics Signs Exclusive Distribution Agreement For Febridx In Romania
Brief: Lumos Diagnostics Posts FY26 Revenue Rises 6% To $13.2 Million